4//SEC Filing
Redmond Paul C 4
Accession 0001225208-12-011559
CIK 0001099800other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:25 PM ET
Size
21.1 KB
Accession
0001225208-12-011559
Insider Transaction Report
Form 4
Redmond Paul C
CVP, CardioVations Surgcl Sys
Transactions
- Tax Payment
Common Stock
2012-05-07$84.99/sh−561$47,679→ 35,007 total - Sale
Common Stock
2012-05-07$85.45/sh−9,351$799,043→ 20,007 total - Tax Payment
Common Stock
2012-05-08$85.49/sh−1,167$99,767→ 36,040 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-05-08−17,200→ 17,200 totalExercise: $27.77From: 2009-05-08Exp: 2015-05-07→ Common Stock (17,200 underlying) - Sale
Common Stock
2012-05-08$85.45/sh−4,999$427,165→ 31,041 total - Exercise/Conversion
Common Stock
2012-05-08$27.77/sh+17,200$477,644→ 37,207 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-05-07−15,000→ 15,000 totalExercise: $31.47From: 2010-05-07Exp: 2016-05-06→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2012-05-07$31.47/sh+15,000$472,050→ 35,568 total - Sale
Common Stock
2012-05-07$84.44/sh−5,649$477,002→ 29,358 total - Sale
Common Stock
2012-05-08$84.75/sh−12,201$1,034,035→ 18,840 total
Footnotes (6)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2011.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $83.83 to $84.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $84.84 to $85.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $85.26 to $85.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $84.26 to $85.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001440661
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 7:25 PM ET
- Size
- 21.1 KB